Cimpress CTO sells 19,251 shares after option exercise

Cimpress plc executive Maarten Wensveen, EVP & Chief Technology Officer, reported an exercise-and-sell transaction in the company’s ordinary shares.

Rhea-AI Filing Summary

Cimpress plc executive Maarten Wensveen, EVP & Chief Technology Officer, reported an exercise-and-sell transaction in the company’s ordinary shares. On May 5, 2026, he exercised options to acquire 10,000 ordinary shares at an exercise price of $46.20 per share.

That same day, he completed multiple open‑market sales totaling 19,251 ordinary shares at weighted‑average prices with per‑share sale prices ranging from $90.59 to $94.79, according to footnotes. After these transactions, he directly owns 38,546 ordinary shares and holds 50,013 options to purchase additional ordinary shares.

Insights

Equity compensation analyst

CTO exercised 10,000 options and made routine open‑market sales totaling 19,251 shares.

The filing shows EVP & CTO Maarten Wensveen exercised options for 10,000 ordinary shares at an exercise price of $46.20 per share, converting part of his equity compensation into common stock. This is recorded as a derivative exercise with a corresponding reduction in option holdings.

On the same date, he executed five open‑market sales totaling 19,251 shares, at weighted‑average prices with actual per‑share sale prices ranging from $90.59 to $94.79. Following these trades, he directly holds 38,546 ordinary shares and 50,013 options, indicating he retains a meaningful equity position. The pattern appears consistent with a standard exercise‑and‑sell liquidity event rather than a complete exit.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 7 txns

Insider Wensveen Maarten

Role EVP & Chief Technology Officer

Sold 19,251 shs ($1.79M)

Approx. gross sale proceeds $1.79M

Approx. exercise cost $462K

Type	Security	Shares	Price	Value
Exercise	Option (right to buy)	10,000	$0.00	$0.00
Exercise	Ordinary Shares	10,000	$46.20	$462K
Sale	Ordinary Shares	379	$90.73	$34K
Sale	Ordinary Shares	2,884	$91.73	$265K
Sale	Ordinary Shares	4,636	$92.39	$428K
Sale	Ordinary Shares	9,797	$93.49	$916K
Sale	Ordinary Shares	1,555	$94.13	$146K

Holdings After Transaction: Option (right to buy) — 50,013 contracts (Direct); Ordinary Shares — 19,674 shares (Direct)

Footnotes (6)

1. F1. Reflects weighted-average sale price (per share prices actually received ranged from $90.59 to $90.85). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range
2. F2. Reflects weighted-average sale price (per share prices actually received ranged from $91.41 to $91.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
3. F3. Reflects weighted-average sale price (per share prices actually received ranged from $92.01 to $92.97). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
4. F4. Reflects weighted-average sale price (per share prices actually received ranged from $93.00 to $93.97). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
5. F5. Reflects weighted-average sale price (per share prices actually received ranged from $94.00 to $94.79). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
6. F6. This option becomes exercisable as to 25% of the original number of shares on the Date Exercisable in Table II, and as to an additional 6.25% of the original number of shares on the last day of each successive fiscal quarter thereafter.

Key Figures

Shares sold: 19,251 shares Sale price range: $90.59–$94.79 per share Options exercised: 10,000 shares +4 more

7 metrics

Shares sold 19,251 shares Total ordinary shares sold on May 5, 2026

Sale price range $90.59–$94.79 per share Actual per-share prices from footnote ranges

Options exercised 10,000 shares Ordinary shares acquired via option exercise

Exercise price $46.20 per share Exercise price of the stock options

Post-transaction share holdings 38,546 shares Ordinary shares owned directly after transactions

Remaining options 50,013 options Derivative securities following option exercise

Net share change -19,251 shares Net buy/sell direction recorded as net-sell

Key Terms

weighted-average sale price, Option (right to buy, derivative security, open-market sale, +2 more

6 terms

weighted-average sale price financial

"Reflects weighted-average sale price (per share prices actually received ranged..."

Option (right to buy financial

"security_title": "Option (right to buy)""

derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Exercise or conversion financial

"transaction_code_description": "Exercise or conversion of derivative security""

Ordinary Shares financial

"security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cimpress (CMPR) executive Maarten Wensveen report in this Form 4?

He reported an exercise-and-sell transaction. Wensveen exercised options for 10,000 Cimpress ordinary shares at $46.20 and sold 19,251 shares in multiple open-market trades, while remaining a significant shareholder after the transactions.

How many Cimpress shares did Maarten Wensveen sell, and at what prices?

He sold 19,251 Cimpress ordinary shares in several open-market transactions. Footnotes state the actual per-share sale prices ranged from $90.59 to $94.79, with each reported transaction line reflecting a weighted-average sale price for its respective trade.

What option exercise did the Cimpress CTO report in this filing?

He exercised stock options covering 10,000 Cimpress ordinary shares at an exercise price of $46.20 per share. A related derivative entry shows 10,000 option rights converted into ordinary shares as part of this transaction sequence on May 5, 2026.

How many Cimpress shares does Maarten Wensveen hold after these transactions?

After the reported trades, he directly owns 38,546 Cimpress ordinary shares. The derivative table also shows he holds 50,013 options to purchase additional ordinary shares, so this filing reflects a partial reduction rather than an exit from his equity position.

Were the Cimpress share sales by Maarten Wensveen part of an open-market transaction?

Yes. Each sale is coded “S” for open-market or private sale and described as an open-market transaction. Footnotes clarify the reported prices are weighted averages, with detailed price ranges available upon request from the reporting person.

Does this Cimpress Form 4 indicate any remaining derivative holdings for the CTO?

Yes. After exercising options for 10,000 shares, the derivative section shows 50,013 options remaining. These options represent additional potential future share acquisitions, separate from the 38,546 ordinary shares he currently owns directly after the reported transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 04:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wensveen Maarten

(Last) (First) (Middle)

CIMPRESS PLC, FIRST FLOOR BUILDING 3

FINNABAIR BUSINESS & TECHNOLOGY PARK

(Street)

DUNDALK, COUNTY LOUTH

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
CIMPRESS plc [ CMPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	05/05/2026		M		10,000	A	$46.2	38,925	D
Ordinary Shares	05/05/2026		S		379	D	$90.73(1)	38,546	D
Ordinary Shares	05/05/2026		S		2,884	D	$91.73(2)	35,662	D
Ordinary Shares	05/05/2026		S		4,636	D	$92.39(3)	31,026	D
Ordinary Shares	05/05/2026		S		9,797	D	$93.49(4)	21,229	D
Ordinary Shares	05/05/2026		S		1,555	D	$94.13(5)	19,674	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	$46.2	05/05/2026		M			10,000	06/30/2023(6)	08/15/2032	Ordinary Shares	10,000	$0	50,013	D

Explanation of Responses:

1. Reflects weighted-average sale price (per share prices actually received ranged from $90.59 to $90.85). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range

2. Reflects weighted-average sale price (per share prices actually received ranged from $91.41 to $91.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

3. Reflects weighted-average sale price (per share prices actually received ranged from $92.01 to $92.97). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

4. Reflects weighted-average sale price (per share prices actually received ranged from $93.00 to $93.97). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

5. Reflects weighted-average sale price (per share prices actually received ranged from $94.00 to $94.79). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

6. This option becomes exercisable as to 25% of the original number of shares on the Date Exercisable in Table II, and as to an additional 6.25% of the original number of shares on the last day of each successive fiscal quarter thereafter.

Remarks:

	/s/ Sean E. Quinn, as attorney-in-fact for Maarten Wensveen	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)